speb/financial-data huggingface dataset:
CBT income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.21
CBT balance_sheet (annual, 2025-09-30) — Total Assets: 3815000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Total Assets: 3815000000.00
CBT balance_sheet (annual, 2025-09-30) — Total Capitalization: 2406000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 2406000000.00
CBT balance_sheet (annual, 2025-09-30) — Total Debt: 1215000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Total Debt: 1215000000.00
CBT balance_sheet (annual, 2025-09-30) — Total Equity Gross Minority Interest: 1705000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 1705000000.00
CBT income_statement (annual, 2025-09-30) — Total Expenses: 3092000000.00
CBT income_statement (quarterly, 2025-09-30) — Total Expenses: 762000000.00
CBT balance_sheet (annual, 2025-09-30) — Total Liabilities Net Minority Interest: 2110000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2110000000.00
CBT balance_sheet (annual, 2025-09-30) — Total Non Current Assets: 2276000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 2276000000.00
CBT balance_sheet (annual, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1153000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 1153000000.00
CBT income_statement (annual, 2025-09-30) — Total Operating Income As Reported: 621000000.00
CBT income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 137000000.00
CBT balance_sheet (annual, 2025-09-30) — Total Tax Payable: 35000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 35000000.00
CBT income_statement (annual, 2025-09-30) — Total Unusual Items: 0.00
CBT income_statement (annual, 2025-09-30) — Total Unusual Items Excluding Goodwill: 0.00
CBT balance_sheet (annual, 2025-09-30) — Treasury Shares Number: 119872.00
CBT balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 119872.00
CBT balance_sheet (annual, 2025-09-30) — Treasury Stock: 3000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 3000000.00
CBT balance_sheet (annual, 2025-09-30) — Working Capital: 582000000.00
CBT balance_sheet (quarterly, 2025-09-30) — Working Capital: 582000000.00
CBT income_statement (quarterly, 2025-12-31) — +Operating Expense: 82000000.00
CBT income_statement (quarterly, 2025-12-31) — +Total Revenue: 849000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 575000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 616000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -2744000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 0.00
CBT balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -5000000.00
CBT income_statement (quarterly, 2025-12-31) — Average Dilution Earnings: 0.00
CBT income_statement (quarterly, 2025-12-31) — Basic Average Shares: 52700000.00
CBT income_statement (quarterly, 2025-12-31) — Basic EPS: 1.38
CBT cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 258000000.00
CBT cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -69000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Capital Stock: 52000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 230000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 230000000.00
CBT cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -24000000.00
CBT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -91000000.00
CBT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -69000000.00
CBT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 126000000.00
CBT cash_flow (quarterly, 2025-12-31) — Change In Account Payable: -61000000.00
CBT cash_flow (quarterly, 2025-12-31) — Change In Income Tax Payable: -7000000.00
CBT cash_flow (quarterly, 2025-12-31) — Change In Inventory: 2000000.00
CBT cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 4000000.00
CBT cash_flow (quarterly, 2025-12-31) — Change In Payable: -68000000.00
CBT cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: -68000000.00
CBT cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: -14000000.00
CBT cash_flow (quarterly, 2025-12-31) — Change In Receivables: 64000000.00
CBT cash_flow (quarterly, 2025-12-31) — Change In Tax Payable: -7000000.00
CBT cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -12000000.00
CBT cash_flow (quarterly, 2025-12-31) — Changes In Cash: -35000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Common Stock: 52000000.00
CBT cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -24000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 1575000000.00
CBT cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 0.00
CBT cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -52000000.00
CBT income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 638000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Current Assets: 1457000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Current Debt: 272000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 272000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 874000000.00
CBT cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 2000000.00
CBT cash_flow (quarterly, 2025-12-31) — Deferred Tax: 2000000.00
CBT cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 41000000.00
CBT cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 41000000.00
CBT income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 52900000.00
CBT income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.37
CBT income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 72000000.00
CBT cash_flow (quarterly, 2025-12-31) — Dividend Received Cfo: 1000000.00
CBT income_statement (quarterly, 2025-12-31) — EBIT: 136000000.00
CBT income_statement (quarterly, 2025-12-31) — EBITDA: 177000000.00
CBT income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest Net Of Tax: 1000000.00
CBT cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -1000000.00
CBT cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 7000000.00
CBT cash_flow (quarterly, 2025-12-31) — End Cash Position: 230000000.00
CBT cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -92000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Finished Goods: 309000000.00
CBT cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 57000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -310000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Goodwill: 136000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 190000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 621000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Gross PPE: 4471000000.00
CBT income_statement (quarterly, 2025-12-31) — Gross Profit: 211000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 27000000.00
CBT income_statement (quarterly, 2025-12-31) — Interest Expense: 18000000.00
CBT income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 18000000.00
CBT income_statement (quarterly, 2025-12-31) — Interest Income: 7000000.00
CBT income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 7000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Inventory: 503000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Invested Capital: 2701000000.00
CBT cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -69000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 17000000.00
CBT cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
CBT cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 0.00
CBT balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 854000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 854000000.00
CBT cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
CBT cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -2000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 17000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Minority Interest: 154000000.00
CBT income_statement (quarterly, 2025-12-31) — Minority Interests: -9000000.00
CBT cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
CBT cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -52000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Net Debt: 896000000.00
CBT income_statement (quarterly, 2025-12-31) — Net Income: 73000000.00
CBT income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 72000000.00
CBT income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 82000000.00
CBT income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 73000000.00
CBT income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 73000000.00
CBT cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 82000000.00
CBT income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 82000000.00
CBT income_statement (quarterly, 2025-12-31) — Net Interest Income: -11000000.00
CBT cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -2000000.00
CBT cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -2000000.00
CBT income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -11000000.00
CBT cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -14000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Net PPE: 1727000000.00
CBT cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -69000000.00
CBT cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 0.00
CBT balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 1385000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 179000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 43000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 179000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 43000000.00
CBT income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 177000000.00
CBT income_statement (quarterly, 2025-12-31) — Normalized Income: 73000000.00
CBT cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 126000000.00
CBT cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -1000000.00
CBT income_statement (quarterly, 2025-12-31) — Operating Income: 129000000.00
CBT income_statement (quarterly, 2025-12-31) — Operating Revenue: 849000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 52215581.00
CBT balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 108000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -310000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 54000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Other Inventories: 67000000.00
CBT cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 10000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 187000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 257000000.00
CBT income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 1000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Payables: 602000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 602000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CBT income_statement (quarterly, 2025-12-31) — Pretax Income: 118000000.00
CBT cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
CBT cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -69000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Raw Materials: 127000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Receivables: 616000000.00
CBT income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 638000000.00
CBT income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 41000000.00
CBT cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -2000000.00
CBT cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -52000000.00
CBT income_statement (quarterly, 2025-12-31) — Research And Development: 13000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 1836000000.00
CBT income_statement (quarterly, 2025-12-31) — Selling General And Administration: 69000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Share Issued: 52335266.00
CBT cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: 0.00
CBT cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 3000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 1575000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 1385000000.00
CBT income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CBT income_statement (quarterly, 2025-12-31) — Tax Provision: 37000000.00
CBT income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.31
CBT balance_sheet (quarterly, 2025-12-31) — Total Assets: 3757000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 2429000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Total Debt: 1126000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 1729000000.00
CBT income_statement (quarterly, 2025-12-31) — Total Expenses: 720000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 2028000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 2300000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 1154000000.00
CBT income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 129000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 27000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 119685.00
CBT balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 3000000.00
CBT balance_sheet (quarterly, 2025-12-31) — Working Capital: 583000000.00
CBT income_statement (quarterly, 2026-03-31) — +Operating Expense: 81000000.00
CBT income_statement (quarterly, 2026-03-31) — +Total Revenue: 904000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 598000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 657000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -2763000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 0.00
CBT balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -5000000.00
CBT income_statement (quarterly, 2026-03-31) — Average Dilution Earnings: 0.00
CBT income_statement (quarterly, 2026-03-31) — Basic Average Shares: 52000000.00
CBT income_statement (quarterly, 2026-03-31) — Basic EPS: 1.27
CBT cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 230000000.00
CBT cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -45000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Capital Stock: 52000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 252000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 252000000.00
CBT cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -24000000.00
CBT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 52000000.00
CBT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -109000000.00
CBT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 77000000.00
CBT cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 10000000.00
CBT cash_flow (quarterly, 2026-03-31) — Change In Income Tax Payable: 5000000.00
CBT cash_flow (quarterly, 2026-03-31) — Change In Inventory: -2000000.00
CBT cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -7000000.00
CBT cash_flow (quarterly, 2026-03-31) — Change In Payable: 15000000.00
CBT cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: 15000000.00
CBT cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -11000000.00
CBT cash_flow (quarterly, 2026-03-31) — Change In Receivables: -27000000.00
CBT cash_flow (quarterly, 2026-03-31) — Change In Tax Payable: 5000000.00
CBT cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -32000000.00
CBT cash_flow (quarterly, 2026-03-31) — Changes In Cash: 21000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Common Stock: 52000000.00
CBT cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -24000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 1568000000.00
CBT cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 0.00
CBT cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -49000000.00
CBT income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 694000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Current Assets: 1547000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Current Debt: 436000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 436000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1068000000.00
CBT cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -16000000.00
CBT cash_flow (quarterly, 2026-03-31) — Deferred Tax: -16000000.00
CBT cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 49000000.00
CBT cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 49000000.00
CBT income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 52200000.00
CBT income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.27
CBT income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 67000000.00
CBT cash_flow (quarterly, 2026-03-31) — Dividend Received Cfo: 0.00
CBT income_statement (quarterly, 2026-03-31) — EBIT: 138000000.00
CBT income_statement (quarterly, 2026-03-31) — EBITDA: 187000000.00
CBT income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest Net Of Tax: 2000000.00
CBT cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: -2000000.00
CBT cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: 1000000.00
CBT cash_flow (quarterly, 2026-03-31) — End Cash Position: 252000000.00
CBT cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 53000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Finished Goods: 310000000.00
CBT cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 32000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -316000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Goodwill: 136000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 189000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 662000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Gross PPE: 4514000000.00
CBT income_statement (quarterly, 2026-03-31) — Gross Profit: 210000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 34000000.00
CBT income_statement (quarterly, 2026-03-31) — Interest Expense: 18000000.00
CBT income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 18000000.00
CBT income_statement (quarterly, 2026-03-31) — Interest Income: 7000000.00
CBT income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 7000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Inventory: 522000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Invested Capital: 2867000000.00
CBT cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -109000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 18000000.00
CBT cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 0.00
CBT cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 169000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 863000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 863000000.00
CBT cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 0.00
CBT cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -2000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 18000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Minority Interest: 119000000.00
CBT income_statement (quarterly, 2026-03-31) — Minority Interests: -10000000.00
CBT cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -66000000.00
CBT cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -49000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Net Debt: 1047000000.00
CBT income_statement (quarterly, 2026-03-31) — Net Income: 68000000.00
CBT income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 67000000.00
CBT income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 78000000.00
CBT income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 68000000.00
CBT income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 68000000.00
CBT cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 78000000.00
CBT income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 78000000.00
CBT income_statement (quarterly, 2026-03-31) — Net Interest Income: -11000000.00
CBT cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 159000000.00
CBT cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -2000000.00
CBT income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -11000000.00
CBT cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -33000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Net PPE: 1751000000.00
CBT cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -45000000.00
CBT cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 161000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 1379000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 198000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 40000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 198000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 40000000.00
CBT income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 187000000.00
CBT income_statement (quarterly, 2026-03-31) — Normalized Income: 68000000.00
CBT cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 77000000.00
CBT cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -2000000.00
CBT income_statement (quarterly, 2026-03-31) — Operating Income: 129000000.00
CBT income_statement (quarterly, 2026-03-31) — Operating Revenue: 904000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 51579624.00
CBT balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 116000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -316000000.00
CBT income_statement (quarterly, 2026-03-31) — Other Income Expense: 2000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 53000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Other Inventories: 68000000.00
CBT cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -4000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 194000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 239000000.00
CBT income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 2000000.00
CBT income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 1000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Payables: 632000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 632000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CBT income_statement (quarterly, 2026-03-31) — Pretax Income: 120000000.00
CBT cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -66000000.00
CBT cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -45000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Raw Materials: 144000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Receivables: 657000000.00
CBT income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 694000000.00
CBT income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 49000000.00
CBT cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -10000000.00
CBT cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -49000000.00
CBT income_statement (quarterly, 2026-03-31) — Research And Development: 14000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 1835000000.00
CBT income_statement (quarterly, 2026-03-31) — Selling General And Administration: 67000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Share Issued: 51694687.00
CBT cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 169000000.00
CBT cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 4000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 1568000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 1379000000.00
CBT income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CBT income_statement (quarterly, 2026-03-31) — Tax Provision: 44000000.00
CBT income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.37
CBT balance_sheet (quarterly, 2026-03-31) — Total Assets: 3897000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 2431000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Total Debt: 1299000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 1687000000.00
CBT income_statement (quarterly, 2026-03-31) — Total Expenses: 775000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 2210000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 2350000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 1142000000.00
CBT income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 129000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 34000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 115063.00
CBT balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 3000000.00
CBT balance_sheet (quarterly, 2026-03-31) — Working Capital: 479000000.00
CBU balance_sheet (annual, 2021-12-31) — Accounts Payable: 210797000.00
CBU income_statement (annual, 2021-12-31) — Other Gand A: 51003000.00
CBU income_statement (annual, 2021-12-31) — Other Special Charges: -100000.00
CBU balance_sheet (annual, 2021-12-31) — Payables: 210797000.00
CBU balance_sheet (annual, 2021-12-31) — Payables And Accrued Expenses: 210797000.00
CBU cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 252000.00
CBU cash_flow (annual, 2021-12-31) — Purchase Of Business: -29975000.00
CBU income_statement (annual, 2022-12-31) — +Total Revenue: 679355000.00
CBU balance_sheet (annual, 2022-12-31) — Accounts Payable: 133863000.00
CBU balance_sheet (annual, 2022-12-31) — Accounts Receivable: 52613000.00
CBU balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -137427000.00
CBU balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 1050231000.00
CBU income_statement (annual, 2022-12-31) — Amortization: 15214000.00
CBU cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 16015000.00
CBU cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 16015000.00
CBU income_statement (annual, 2022-12-31) — Amortization Of Intangibles Income Statement: 15214000.00
CBU cash_flow (annual, 2022-12-31) — Amortization Of Securities: -18738000.00
CBU balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 4701000.00
CBU income_statement (annual, 2022-12-31) — Basic Average Shares: 54046264.00
CBU income_statement (annual, 2022-12-31) — Basic EPS: 3.48
CBU cash_flow (annual, 2022-12-31) — Beginning Cash Position: 1875064000.00
CBU balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 158312000.00
CBU cash_flow (annual, 2022-12-31) — Capital Expenditure: -12922000.00
CBU balance_sheet (annual, 2022-12-31) — Capital Stock: 54190000.00
CBU balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 209896000.00
CBU balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Federal Funds Sold: 209896000.00
CBU cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -93387000.00
CBU cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 259217000.00
CBU cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -2138985000.00
CBU cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 214600000.00
CBU cash_flow (annual, 2022-12-31) — Change In Working Capital: -6231000.00
CBU cash_flow (annual, 2022-12-31) — Changes In Cash: -1665168000.00
CBU balance_sheet (annual, 2022-12-31) — Common Stock: 54190000.00
CBU cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -93387000.00
CBU balance_sheet (annual, 2022-12-31) — Common Stock Equity: 1551705000.00
CBU cash_flow (annual, 2022-12-31) — Common Stock Issuance: 1184000.00
CBU cash_flow (annual, 2022-12-31) — Common Stock Payments: -16614000.00
CBU balance_sheet (annual, 2022-12-31) — Construction In Progress: 2377000.00
CBU balance_sheet (annual, 2022-12-31) — Current Debt: 768400000.00
CBU balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 768400000.00
CBU cash_flow (annual, 2022-12-31) — Deferred Income Tax: 1309000.00
CBU cash_flow (annual, 2022-12-31) — Deferred Tax: 1309000.00
CBU cash_flow (annual, 2022-12-31) — Depreciation: 14411000.00
CBU cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 30426000.00
CBU income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 15214000.00
CBU cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 30426000.00
CBU income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 15214000.00
CBU income_statement (annual, 2022-12-31) — Diluted Average Shares: 54358671.00
CBU income_statement (annual, 2022-12-31) — Diluted EPS: 3.46
CBU income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 187548000.00
CBU cash_flow (annual, 2022-12-31) — End Cash Position: 209896000.00
CBU cash_flow (annual, 2022-12-31) — Financing Cash Flow: 259217000.00
CBU cash_flow (annual, 2022-12-31) — Free Cash Flow: 201678000.00
CBU cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: 0.00
CBU income_statement (annual, 2022-12-31) — Gain On Sale Of Security: -44000.00
CBU balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -686439000.00
CBU income_statement (annual, 2022-12-31) — General And Administrative Expense: 257339000.00
CBU balance_sheet (annual, 2022-12-31) — Goodwill: 841841000.00
CBU balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 902837000.00
CBU balance_sheet (annual, 2022-12-31) — Gross PPE: 298205000.00
CBU balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 1079695000.00
CBU cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 57131000.00
CBU income_statement (annual, 2022-12-31) — Interest Expense: 23099000.00
CBU income_statement (annual, 2022-12-31) — Interest Income: 443729000.00
CBU cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 23402000.00
CBU balance_sheet (annual, 2022-12-31) — Invested Capital: 2342828000.00
CBU cash_flow (annual, 2022-12-31) — Investing Cash Flow: -2138985000.00
CBU balance_sheet (annual, 2022-12-31) — Investments And Advances: 5236247000.00
CBU cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 1184000.00
CBU cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
CBU balance_sheet (annual, 2022-12-31) — Land And Improvements: 34487000.00
CBU balance_sheet (annual, 2022-12-31) — Long Term Debt: 22723000.00
CBU balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 22723000.00
CBU cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
CBU cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -95000.00
CBU cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -915000.00
CBU cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -15430000.00
CBU balance_sheet (annual, 2022-12-31) — Net Debt: 581227000.00
CBU income_statement (annual, 2022-12-31) — Net Income: 188081000.00
CBU income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 187548000.00
CBU income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 188081000.00
CBU income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 188081000.00
CBU income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 188081000.00
CBU cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 188081000.00
CBU income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 188081000.00
CBU income_statement (annual, 2022-12-31) — Net Interest Income: 420630000.00
CBU cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -1123839000.00
CBU cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 768305000.00
CBU cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -95000.00
CBU cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -1284000.00
CBU balance_sheet (annual, 2022-12-31) — Net PPE: 160778000.00
CBU cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -10490000.00
CBU cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 768400000.00
CBU balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 648868000.00
CBU income_statement (annual, 2022-12-31) — Normalized Income: 191777543.00
CBU income_statement (annual, 2022-12-31) — Occupancy And Equipment: 42413000.00
CBU cash_flow (annual, 2022-12-31) — Operating Cash Flow: 214600000.00
CBU cash_flow (annual, 2022-12-31) — Operating Gains Losses: -655000.00
CBU income_statement (annual, 2022-12-31) — Operating Revenue: 679355000.00
CBU balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 53737249.00
CBU balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 768400000.00
CBU balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -686439000.00
CBU balance_sheet (annual, 2022-12-31) — Other Equity Interest: 7756000.00
CBU balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 60996000.00
CBU cash_flow (annual, 2022-12-31) — Other Non Cash Items: -2147000.00
CBU income_statement (annual, 2022-12-31) — Other Non Interest Expense: 77468000.00
CBU balance_sheet (annual, 2022-12-31) — Other Properties: 103029000.00
CBU balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 4151851000.00
CBU income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 533000.00
CBU balance_sheet (annual, 2022-12-31) — Payables: 133863000.00
CBU balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 133863000.00
CBU balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CBU income_statement (annual, 2022-12-31) — Pretax Income: 240314000.00
CBU cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 236000.00
CBU income_statement (annual, 2022-12-31) — Professional Expense And Contract Services Expense: 14018000.00
CBU cash_flow (annual, 2022-12-31) — Purchase Of Business: -915000.00
CBU cash_flow (annual, 2022-12-31) — Purchase Of Investment: -1390778000.00
CBU cash_flow (annual, 2022-12-31) — Purchase Of PPE: -12922000.00
CBU balance_sheet (annual, 2022-12-31) — Receivables: 52613000.00
CBU income_statement (annual, 2022-12-31) — Reconciled Depreciation: 30426000.00
CBU cash_flow (annual, 2022-12-31) — Repayment Of Debt: -95000.00
CBU cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -16614000.00
CBU income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 4721000.00
CBU balance_sheet (annual, 2022-12-31) — Retained Earnings: 1152452000.00
CBU income_statement (annual, 2022-12-31) — Salaries And Wages: 257339000.00
CBU cash_flow (annual, 2022-12-31) — Sale Of Investment: 266939000.00
CBU cash_flow (annual, 2022-12-31) — Sale Of PPE: 2432000.00
CBU income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 13095000.00
CBU income_statement (annual, 2022-12-31) — Selling General And Administration: 270434000.00
CBU balance_sheet (annual, 2022-12-31) — Share Issued: 54190201.00
CBU income_statement (annual, 2022-12-31) — Special Income Charges: -4721000.00
CBU cash_flow (annual, 2022-12-31) — Stock Based Compensation: 7738000.00
CBU balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1551705000.00
CBU balance_sheet (annual, 2022-12-31) — Tangible Book Value: 648868000.00
CBU income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -1024457.00
CBU income_statement (annual, 2022-12-31) — Tax Provision: 52233000.00
CBU income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.22
CBU balance_sheet (annual, 2022-12-31) — Total Assets: 15835651000.00
CBU balance_sheet (annual, 2022-12-31) — Total Capitalization: 1574428000.00
CBU balance_sheet (annual, 2022-12-31) — Total Debt: 791123000.00
CBU balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1551705000.00
CBU balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 14283946000.00
CBU income_statement (annual, 2022-12-31) — Total Unusual Items: -4721000.00
CBU income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -4721000.00
CBU balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 452952.00
CBU balance_sheet (annual, 2022-12-31) — Treasury Stock: 26485000.00
CBU cash_flow (annual, 2022-12-31) — Unrealized Gain Loss On Investment Securities: 44000.00
CBU income_statement (annual, 2023-12-31) — +Total Revenue: 651877000.00
CBU balance_sheet (annual, 2023-12-31) — Accounts Receivable: 54534000.00
CBU balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -135085000.00
CBU balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 1060289000.00
CBU income_statement (annual, 2023-12-31) — Amortization: 14511000.00
CBU cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 15360000.00
CBU cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 15360000.00
CBU income_statement (annual, 2023-12-31) — Amortization Of Intangibles Income Statement: 14511000.00
CBU cash_flow (annual, 2023-12-31) — Amortization Of Securities: 5838000.00
CBU balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 7052000.00
CBU income_statement (annual, 2023-12-31) — Basic Average Shares: 53742520.00
CBU income_statement (annual, 2023-12-31) — Basic EPS: 2.54
CBU cash_flow (annual, 2023-12-31) — Beginning Cash Position: 209896000.00
CBU balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 155146000.00
CBU cash_flow (annual, 2023-12-31) — Capital Expenditure: -18585000.00
CBU balance_sheet (annual, 2023-12-31) — Capital Stock: 54372000.00
CBU balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 190962000.00
CBU balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Federal Funds Sold: 190962000.00
CBU cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -95102000.00
CBU cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -583130000.00
CBU cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 335776000.00
CBU cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 228420000.00
CBU cash_flow (annual, 2023-12-31) — Change In Working Capital: 1106000.00
CBU cash_flow (annual, 2023-12-31) — Changes In Cash: -18934000.00
CBU balance_sheet (annual, 2023-12-31) — Common Stock: 54372000.00
CBU cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -95102000.00
CBU balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1697937000.00
CBU cash_flow (annual, 2023-12-31) — Common Stock Issuance: 1015000.00
CBU cash_flow (annual, 2023-12-31) — Common Stock Payments: -30016000.00
CBU balance_sheet (annual, 2023-12-31) — Construction In Progress: 7995000.00
CBU balance_sheet (annual, 2023-12-31) — Current Debt: 53000000.00
CBU balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 53000000.00
CBU cash_flow (annual, 2023-12-31) — Deferred Income Tax: -7503000.00
CBU cash_flow (annual, 2023-12-31) — Deferred Tax: -7503000.00
CBU cash_flow (annual, 2023-12-31) — Depreciation: 12991000.00
CBU cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 28351000.00
CBU income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 14511000.00
CBU cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 28351000.00
CBU income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 14511000.00
CBU income_statement (annual, 2023-12-31) — Diluted Average Shares: 53954941.00
CBU income_statement (annual, 2023-12-31) — Diluted EPS: 2.53
CBU income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 131477000.00
CBU cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 0.00
CBU cash_flow (annual, 2023-12-31) — End Cash Position: 190962000.00
CBU cash_flow (annual, 2023-12-31) — Financing Cash Flow: -583130000.00
CBU cash_flow (annual, 2023-12-31) — Free Cash Flow: 209835000.00
CBU cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 52329000.00
CBU income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -52376000.00
CBU balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -556892000.00
CBU income_statement (annual, 2023-12-31) — General And Administrative Expense: 281803000.00
CBU balance_sheet (annual, 2023-12-31) — Goodwill: 845396000.00
CBU balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 897987000.00
CBU balance_sheet (annual, 2023-12-31) — Gross PPE: 308503000.00
CBU balance_sheet (annual, 2023-12-31) — Held To Maturity Securities: 1172174000.00
CBU cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 41661000.00
CBU income_statement (annual, 2023-12-31) — Interest Expense: 104103000.00
CBU income_statement (annual, 2023-12-31) — Interest Income: 541388000.00
CBU cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 100040000.00
CBU balance_sheet (annual, 2023-12-31) — Invested Capital: 2158540000.00
CBU cash_flow (annual, 2023-12-31) — Investing Cash Flow: 335776000.00
CBU balance_sheet (annual, 2023-12-31) — Investments And Advances: 4099218000.00
CBU cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 1015000.00
CBU cash_flow (annual, 2023-12-31) — Issuance Of Debt: 400000000.00
CBU balance_sheet (annual, 2023-12-31) — Land And Improvements: 33954000.00
CBU balance_sheet (annual, 2023-12-31) — Long Term Debt: 407603000.00
CBU balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 407603000.00
CBU cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 400000000.00
CBU cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -14971000.00
CBU cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -8517000.00
CBU cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -29001000.00
CBU balance_sheet (annual, 2023-12-31) — Net Debt: 269641000.00
CBU income_statement (annual, 2023-12-31) — Net Income: 131924000.00
CBU income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 131477000.00
CBU income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 131924000.00
CBU income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 131924000.00
CBU income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 131924000.00
CBU cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 131924000.00
CBU income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 131924000.00
CBU income_statement (annual, 2023-12-31) — Net Interest Income: 437285000.00
CBU cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 1278685000.00
CBU cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -330371000.00
CBU cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 385029000.00
CBU cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -2411000.00
CBU balance_sheet (annual, 2023-12-31) — Net PPE: 173418000.00
CBU cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -11112000.00
CBU cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -715400000.00
CBU balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 799950000.00
CBU income_statement (annual, 2023-12-31) — Normalized Income: 139814176.00
CBU income_statement (annual, 2023-12-31) — Occupancy And Equipment: 42550000.00
CBU cash_flow (annual, 2023-12-31) — Operating Cash Flow: 228420000.00
CBU cash_flow (annual, 2023-12-31) — Operating Gains Losses: 50597000.00
CBU income_statement (annual, 2023-12-31) — Operating Revenue: 651877000.00
CBU balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 53327060.00
CBU balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 53000000.00
CBU balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -556892000.00
CBU balance_sheet (annual, 2023-12-31) — Other Equity Interest: 6891000.00
CBU balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 52591000.00
CBU cash_flow (annual, 2023-12-31) — Other Non Cash Items: -2412000.00
CBU income_statement (annual, 2023-12-31) — Other Non Interest Expense: 91863000.00
CBU balance_sheet (annual, 2023-12-31) — Other Properties: 111408000.00
CBU balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 2919992000.00
CBU income_statement (annual, 2023-12-31) — Other Special Charges: 5800000.00
CBU income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 447000.00
CBU balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CBU income_statement (annual, 2023-12-31) — Pretax Income: 168231000.00
CBU cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 217000.00
CBU income_statement (annual, 2023-12-31) — Professional Expense And Contract Services Expense: 15921000.00
CBU cash_flow (annual, 2023-12-31) — Purchase Of Business: -8517000.00
CBU cash_flow (annual, 2023-12-31) — Purchase Of Investment: -68080000.00
CBU cash_flow (annual, 2023-12-31) — Purchase Of PPE: -18585000.00
CBU balance_sheet (annual, 2023-12-31) — Receivables: 54534000.00
CBU income_statement (annual, 2023-12-31) — Reconciled Depreciation: 28351000.00
CBU cash_flow (annual, 2023-12-31) — Repayment Of Debt: -14971000.00
CBU cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -30016000.00
CBU income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 4506000.00
CBU balance_sheet (annual, 2023-12-31) — Retained Earnings: 1188869000.00
CBU income_statement (annual, 2023-12-31) — Salaries And Wages: 281803000.00
CBU cash_flow (annual, 2023-12-31) — Sale Of Investment: 1346765000.00
CBU cash_flow (annual, 2023-12-31) — Sale Of PPE: 7473000.00
CBU income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 15731000.00
CBU income_statement (annual, 2023-12-31) — Selling General And Administration: 297534000.00
CBU balance_sheet (annual, 2023-12-31) — Share Issued: 54372292.00
CBU income_statement (annual, 2023-12-31) — Special Income Charges: -10064000.00
CBU cash_flow (annual, 2023-12-31) — Stock Based Compensation: 9269000.00
CBU balance_sheet (annual, 2023-12-31) — Stockholders Equity: 1697937000.00